Locations:

Tag: nucleic acid therapeutics

19-HVI-1792159; Steven Nissen, M.D., M.A.C.C.; Mike Viars

January 4, 2024/Heart, Vascular and Thoracic/Preventive Cardiology

Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk

It's time to increase testing for this major cardiovascular risk factor in advance of new therapies

November 13, 2023/Heart, Vascular and Thoracic/Preventive Cardiology

Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks

Undetectable levels achieved for nearly nine months in phase 1 trial

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy